Sector
PharmaceuticalsOpen
₹12.21Prev. Close
₹12.21Turnover(Lac.)
₹0.52Day's High
₹12.21Day's Low
₹12.2152 Week's High
₹12.2152 Week's Low
₹7.91Book Value
₹10.4Face Value
₹10Mkt Cap (₹ Cr.)
28.95P/E
0EPS
0Divi. Yield
04 Dec 2024
12:00 AM
EGM
2 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
9 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 6.94 | 4.39 | 4.39 | 4.39 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -5.86 | -5.12 | -4.78 | -4.6 |
Net Worth | 1.08 | -0.73 | -0.39 | -0.21 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 1.8 |
yoy growth (%) | 0 | 0 | -100 | -76.3 |
Raw materials | 0 | 0 | 0 | -1.27 |
As % of sales | 0 | 0 | 0 | 70.86 |
Employee costs | -0.04 | 0 | -0.03 | -1.17 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -0.18 | -0.05 | -0.16 | -1.41 |
Depreciation | -0.03 | -0.03 | -0.03 | -0.13 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.1 | 0 | -0.12 | -0.9 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | -100 | -76.3 |
Op profit growth | 198.36 | -63.66 | -86.72 | -334.74 |
EBIT growth | 207.45 | -63.16 | -86.27 | -477.56 |
Net profit growth | 202.1 | -63.82 | -93 | -1,909.97 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director & CFO
B V Anatha Kumar
Independent Director
Ananthkumar Shilpa
Executive Director
KUNIAMUTHUR NANJAPPAN ANAND
Company Sec. & Compli. Officer
Monika Sanwal
Independent Director
A Anitha
Managing Director
N Aravind
270 Shastri Market Indore,
Madhya Pradesh - 452007
Tel: -
Website: http://www.kabradrugs.com
Email: kabradrugs@gmail.com
Plot No. 60,
Electronic Complex, Pardeshipura,
Indore - 452010
Tel: 91-0731-3198601/3198
Website: www.ankitonline.org
Email: ankit_4321@yahoo.com
Summary
Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solv...
Read More
Reports by Kabra Drugs Ltd
What is the Kabra Drugs Ltd share price today?
What is the Market Cap of Kabra Drugs Ltd?
What is the PE and PB ratio of Kabra Drugs Ltd?
What is the 52 Week High and Low of Kabra Drugs Ltd?
What is the CAGR of Kabra Drugs Ltd?
What is the shareholding pattern of Kabra Drugs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.